ULS

UL Solutions Inc.

$82.20

-2.04%
Mar 31, 2026
Bobby Quantitative Model
UL Solutions Inc. is a global leader in product testing, inspection, and certification (TIC) services within the Specialty Business Services industry. It is a for-profit entity with a core narrative centered on its established global position and expertise in ensuring product safety and compliance.

People also watch

Cintas

Cintas

CTAS

Analysis
Copart

Copart

CPRT

Analysis
Ritchie Bros. Auctioneers

Ritchie Bros. Auctioneers

RBA

Analysis
Global Payments

Global Payments

GPN

Analysis
Aramark

Aramark

ARMK

Analysis

BobbyInvestment Opinion: Should I buy ULS Today?

Based on a synthesis of the data, the objective assessment for ULS is a Hold. The company's strong fundamentals, including robust revenue growth, high returns on equity, and solid cash flow, are compelling. However, these are fully reflected, if not over-reflected, in the current premium valuation. The stock appears fairly valued at present, with significant near-term risk from its high multiples and mixed earnings momentum. Investors should await a more attractive entry point or clearer signs of margin re-expansion before establishing new positions.

Sign up to view all

ULS 12-Month Price Forecast

The strong operational story is offset by a full valuation. The base case of range-bound trading is most probable, with the stock oscillating between support near its recent lows and resistance near its 52-week high.

Historical Price
Current Price $82.2
Average Target $81.5
High Target $96
Low Target $60

Wall Street consensus

Most Wall Street analysts maintain a constructive view on UL Solutions Inc.'s 12-month outlook, with a consensus price target around $106.86 and implied upside of +30.0% versus the current price.

Average Target

$106.86

5 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

5

covering this stock

Price Range

$66 - $107

Analyst target range

Buy
1 (20%)
Hold
2 (40%)
Sell
2 (40%)

Wall Street analyst coverage for ULS is limited, with only 5 analysts providing estimates. The consensus estimated EPS for the period is $2.75, with a range from $2.48 to $3.02. Recent institutional ratings show a mix of opinions, including 'Buy'/'Overweight'/'Outperform' from B of A Securities, Wells Fargo, and Baird, and 'Neutral' ratings from Citigroup, UBS, and JP Morgan. No specific consensus target price is provided in the data.

Drowning in data?

Find the real signal!

Bulls vs Bears: ULS Investment Factors

ULS presents a mixed picture. The company demonstrates strong operational performance, market-beating returns, and a healthy financial foundation. However, these positives are counterbalanced by a premium valuation, recent margin compression, and notable short interest, creating a balanced risk-reward profile.

Bullish

  • Strong Market Outperformance: Up 16% in 6 months vs. SPY down 6%, showing resilience.
  • Solid Revenue Growth: Q4 revenue grew 6.8% YoY, indicating steady demand.
  • Excellent Profitability Metrics: High ROE of 25.1% and ROA of 12.1% signal efficiency.
  • Healthy Cash Flow Generation: TTM free cash flow of $403M supports financial flexibility.

Bearish

  • Elevated Valuation Multiples: Trailing P/E of 48.8 and P/S of 5.2 appear stretched.
  • Recent Profitability Pressure: Q4 net margin fell to 8.4% from 11.0% a year ago.
  • High Short Interest: Short ratio of 3.89 suggests significant bearish sentiment.
  • Recent Price Volatility: Sharp correction from $91 high shows susceptibility to pullbacks.

ULS Technical Analysis

The stock has demonstrated strong overall performance over the last six months, gaining 16.27%, significantly outperforming the broader market (SPY -5.57%). The price has been volatile, reaching a high near $91.21 in late November 2025 before a sharp correction. In the short term, the stock is down 2.11% over the past month but up 2.37% over the past three months, again outperforming the market which declined 7.32% and 7.87% over the same periods, respectively. The current price of $82.20 sits in the upper half of its 52-week range ($49.93 to $91.95), approximately 10.6% below its yearly high, indicating the stock has retreated from recent peaks but remains well-supported above its yearly low.

Beta

Max Drawdown

-24.3%

Largest decline past year

52-Week Range

$50-$92

Price range past year

Annual Return

+47.6%

Cumulative gain past year

PeriodULS ReturnS&P 500
1m-2.1%-7.9%
3m+2.4%-7.3%
6m+16.3%-5.6%
1y+47.6%+13.0%
ytd+1.6%-7.3%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

ULS Fundamental Analysis

Revenue in Q4 2025 was $789 million, representing a 6.77% year-over-year growth from the same quarter in 2024. Profitability showed some pressure, with the net income margin declining to 8.37% in Q4 2025 from 10.96% in Q4 2024, and diluted EPS dropping to $0.32 from $0.40. The company maintains a moderate debt-to-equity ratio of 0.64 and a healthy current ratio of 1.32. Cash flow generation is solid, with trailing twelve-month free cash flow of $403 million and positive operating cash flow of $144 million in the latest quarter. Operational efficiency is highlighted by a strong Return on Equity (ROE) of 25.12% and a Return on Assets (ROA) of 12.08%.

Quarterly Revenue

$789000000.0B

2025-12

Revenue YoY Growth

+0.06%

YoY Comparison

Gross Margin

+0.48%

Latest Quarter

Free Cash Flow

$403000000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Open an Account, get $2 TSLA now!

Valuation Analysis: Is ULS Overvalued?

Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E is elevated at 48.77, while the forward P/E based on estimated EPS is 33.05. The Price-to-Sales (P/S) ratio is 5.19 and the Enterprise Value-to-Sales (EV/Sales) is 5.55. Peer comparison data is not available in the provided inputs to contextualize these multiples.

PE

48.8x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 19x~60x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

22.2x

Enterprise Value Multiple

Investment Risk Disclosure

The primary risk for ULS is its high valuation. With a trailing P/E of 48.8 and forward P/E of 33.1, the stock is priced for significant future growth. Any earnings disappointment or slowdown in revenue growth could lead to a sharp multiple contraction, as evidenced by the recent ~15% pullback from its November highs. The elevated short ratio of 3.89 underscores this market skepticism.

Operational risks include the recent margin pressure, with net income margin declining in Q4 2025. This could indicate rising costs or competitive pressures within the TIC industry. Furthermore, the company's performance is tied to global industrial and consumer product cycles; an economic downturn could reduce demand for testing and certification services. The limited Wall Street analyst coverage (only 5 analysts) adds to the risk by potentially reducing market liquidity and increasing price volatility on news.

FAQ

The key risks are valuation-related and operational. The high P/E ratio makes the stock vulnerable to a sharp decline if earnings growth slows or misses estimates. Operationally, the recent decline in net income margin from 11.0% to 8.4% year-over-year is a concern. Additionally, high short interest (short ratio 3.89) indicates significant bearish sentiment that could amplify downward moves.

The 12-month outlook is for range-bound trading with a neutral bias. The base case (60% probability) sees the stock trading between $75 and $88, based on meeting consensus EPS of $2.75 and a forward P/E near 30-32x. The bull case targets $90-$96 if EPS hits the high estimate of $3.02. The bear case risks a fall to $60-$72 if margins compress further and the P/E contracts.

Based on traditional metrics, ULS appears overvalued. Its trailing P/E of 48.8 is very high, and its forward P/E of 33.1, while lower, still implies significant growth expectations. The Price-to-Sales ratio of 5.2 also suggests a premium valuation. The stock's value is supported by excellent profitability (ROE of 25.1%), but the current price leaves little room for disappointment, indicating it is fully valued.

At its current price, ULS is not an obvious buy. The company's strong fundamentals, including a 25.1% ROE and 6.8% revenue growth, are attractive. However, these positives are counterbalanced by a high trailing P/E of 48.8 and recent pressure on profit margins. The stock appears fairly valued, making it more of a 'Hold' than a compelling 'Buy' for new investors at this juncture.

ULS is more suitable for a long-term investment horizon. The company's strong market position and solid cash flow generation support a durable business model. However, the high valuation and recent volatility make it a challenging short-term trade. Long-term investors can potentially ride out valuation fluctuations to benefit from the company's underlying growth, while short-term traders face significant risk from multiple compression.